Magnetar Financial’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$210K Sell
3,115
-984
-24% -$65.6K ﹤0.01% 925
2026
Q1
$254K Sell
4,099
-10,192
-71% -$710K ﹤0.01% 813
2025
Q4
$948K Sell
14,291
-90,017
-86% -$5.82M 0.01% 449
2025
Q3
$7.02M Buy
104,308
+375
+0.4% +$29.7K 0.04% 173
2025
Q2
$8.63M Sell
103,933
-32,163
-24% -$2.52M 0.04% 162
2025
Q1
$9.29M Buy
136,096
+47,746
+54% +$3.9M 0.12% 115
2024
Q4
$6.87M Buy
+88,350
New +$6.54M 0.16% 103
2024
Q3
Sell
-280,407
Closed -$31.8M 569
2024
Q2
$31.8M Buy
+280,407
New +$35.5M 0.66% 52
2023
Q4
Sell
-386,809
Closed -$36.1M 419
2023
Q3
$36.1M Buy
+386,809
New +$43.6M 0.92% 31
2022
Q1
Sell
-17,320
Closed -$2.33M 1388
2021
Q4
$2.33M Buy
+17,320
New +$2.49M 0.02% 645
2021
Q1
Sell
-10,648
Closed -$984K 1081
2020
Q4
$984K Sell
10,648
-11,360
-52% -$1.01M 0.01% 465
2020
Q3
$2.27M Buy
+22,008
New +$2.3M 0.04% 226

Other funds holding DXCM

Magnetar Financial's DXCM Position: Q2 2026 in Review

Magnetar Financial reduced its DexCom (DXCM) stake by 24% in Q2 2026, selling an estimated $65.6K and leaving 3,115 shares worth $210K. The position accounts for ﹤0.01% of the portfolio, ranked #925.

Magnetar Financial first reported a position in DXCM in Q3 2020 and has held it in 12 quarters since. The position peaked at $36.1M in Q3 2023. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Magnetar Financial held 3,115 shares of DexCom worth $210K as of Q2 2026.
  • Magnetar Financial sold 984 DexCom shares in Q2 2026, an estimated $65.6K.
  • DexCom made up ﹤0.01% of Magnetar Financial's portfolio in Q2 2026, its #925 holding.
  • Magnetar Financial first reported a position in DexCom in Q3 2020 and has held it in 12 quarters since.
  • Magnetar Financial's DexCom position peaked at $36.1M in Q3 2023.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.